Work

Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium

Year: 2023

Type: article

Study design: Observational Study

Source: European Urology

DOI: 10.1016/j.eururo.2023.04.028

Authors: Johan Bjerner, Ola Bratt, Kirsti Aas, Peter C. Albertsen, Sophie D. Fosså, Rune Kvåle, Hans Lilja, Christoph Müller, Stig Müller, Andreas Stensvold, Owen Thomas, Oluf D. Røe, Andrew Vickers, Jochen Walz, Sigrid V. Carlsson, Jan Oldenburg

Institutions: Sahlgrenska University Hospital, University of Gothenburg, Oslo University Hospital, UConn Health, University of Oslo, Norwegian Institute of Public Health, Haukeland University Hospital, Memorial Sloan Kettering Cancer Center, Lund University, Skåne University Hospital, Sørlandet Sykehus, Akershus University Hospital, Østfold Hospital Trust, Norwegian University of Science and Technology, Levanger Hospital, Helse Nord-Trøndelag HF, Institut Paoli-Calmettes

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Pfizer, Västra Götalandsregionen, OPKO Health, Eisai, Astellas Pharma, Ipsen, EAU Research Foundation, National Institutes of Health, National Cancer Institute, Cilag

Awards: Improving shared decision making in cancer screening, Cancer Center Support Grant

OpenAlex ID: W4375949277

FWCI: 2.948

Cites: 13

Cited by: 16

Related to: 10